A multi-gene expression profile panel for predicting liver metastasis: An algorithmic approach
Open Access
- 1 November 2018
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 13 (11) , e0206400
Abstract
Liver metastasis has been found to affect outcome in prostate, pancreatic and colorectal cancers, but its role in lung cancer is unclear. The 5 year survival rate remains extensively low owing to intrinsic resistance to conventional therapy which can be attributed to the genetic modulators involved in the pathogenesis of the disease. Thus, this study aims to generate a model for early diagnosis and timely treatment of liver metastasis in lung cancer patients. mRNA expression of 15 genes was quantified by real time PCR on lung cancer specimens with (n = 32) and without (n = 30) liver metastasis and their normal counterparts. Principal Component analysis, linear discriminant analysis and hierarchical clustering were conducted to obtain a predictive model. The accuracy of the models was tested by performing Receiver Operating Curve analysis. The expression profile of all the 15 genes were subjected to PCA and LDA analysis and 5 models were generated. ROC curve analysis was performed for all the models and the individual genes. It was observed that out of the 15 genes only 8 genes showed significant sensitivity and specificity. Another model consisting of the selected eight genes was generated showing a specificity and sensitivity of 90.0 and 96.87 respectively (p <0.0001). Moreover, hierarchical clustering showed that tumors with a greater fold change lead to poor prognosis. Our study led to the generation of a concise, biologically relevant multi-gene panel that significantly and non-invasively predicts liver metastasis in lung cancer patients.Keywords
Funding Information
- Gujarat Cancer Society (RE/74/14)
This publication has 37 references indexed in Scilit:
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Downregulation of cell surface CA125/MUC16 induces epithelial-to-mesenchymal transition and restores EGFR signalling in NIH:OVCAR3 ovarian carcinoma cellsBritish Journal of Cancer, 2011
- A Unique Metastasis Gene Signature Enables Prediction of Tumor Relapse in Early-Stage Hepatocellular Carcinoma PatientsCancer Research, 2010
- A blood‐based biomarker panel for stratifying current risk for colorectal cancerInternational Journal of Cancer, 2009
- Molecular pathogenesis and its therapeutic modalities of lung cancer metastasis to boneCancer and Metastasis Reviews, 2007
- Predicting Survival within the Lung Cancer Histopathological Hierarchy Using a Multi-Scale Genomic Model of DevelopmentPLOS Medicine, 2006
- Mechanisms of Bone MetastasisNew England Journal of Medicine, 2004
- Gene-expression profiles predict survival of patients with lung adenocarcinomaNature Medicine, 2002
- Comparison of Discrimination Methods for the Classification of Tumors Using Gene Expression DataJournal of the American Statistical Association, 2002
- Metastatic Pattern in Non-resectable Non-small Cell Lung CancerActa Oncologica, 1999